NCT06215040 The Treatment Effect for Asymptomatic Common Bile Duct Stone
| NCT ID | NCT06215040 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kyungpook National University Hospital |
| Condition | Choledocholithiasis |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-01-02 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-01-02 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is prospective, multicenter study for identify the characteristics of asymptomatic common bile duct stones and effectiveness of treatment.
Eligibility Criteria
Inclusion Criteria: * diagnosed as common bile duct stone by image modality examination * agreement for this study enrollment Exclusion Criteria: * no definite common bile duct stone by image modality examination * symptomatic patients who complain with fever/abdominal pain that compatible with common bile duct stone related symptom * previously diagnosed as pancreatobiliary malignancy * previously treated by endoscopic or percutaneous treatment for bile duct stones * severe cardio or pulmonary disease * pregnancy or possibility of pregnancy * who do not agree with study enrollment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06215040 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Choledocholithiasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06215040 currently recruiting?
Yes, NCT06215040 is actively recruiting participants. Contact the research team at hero797@hanmail.net for enrollment information.
Where is the NCT06215040 trial being conducted?
This trial is being conducted at Daegu, South Korea.
Who is sponsoring the NCT06215040 clinical trial?
NCT06215040 is sponsored by Kyungpook National University Hospital. The trial plans to enroll 120 participants.